MediWound Ltd

+0.07 (+4.02%)
Earnings Announcements

Mediwound Reports Fourth Quarter And Full Year 2021 Financial Results

Published: 03/17/2022 11:25 GMT
MediWound Ltd (MDWD) - Mediwound Reports Fourth Quarter and Full Year 2021 Financial Results.
Q4 Revenue Fell 18 Percent to $5.5 Million.
Q4 Loss per Share $0.15.
Achieved Profitability With Commercial Operations for Nexobrid for 2021.
Believe Existing Cash and Cash Equivalents Will Be Sufficient to Fund Anticipated Operating Expenses for at Least Next 24 Months.
Revenue is expected to be $5.27 Million
Adjusted EPS is expected to be -$0.10

Next Quarter Revenue Guidance is expected to be $4.74 Million
Next Quarter EPS Guidance is expected to be -$0.09

More details on our Analysts Page.